By | October 04 2010 9:09 AM

Indian drugmaker Fresenius Kabi Oncology Ltd has seen two batches of a cancer drug shipped to the U.S. being recalled by its German parent, Fresenius Kabi Pharmaceuticals Holdin Inc, the Economic Times reported on Monday.